MDxHealth SA (MDXH)
NASDAQ: MDXH · Real-Time Price · USD
0.427
-0.028 (-6.12%)
At close: Jun 26, 2026, 4:00 PM EDT
0.440
+0.013 (3.09%)
After-hours: Jun 26, 2026, 7:50 PM EDT
MDxHealth Stock Forecast
MDXH's stock price has decreased by -80.86% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
The 4 analysts with 12-month price forecasts for MDxHealth stock have an average target of 3.38, with a low estimate of 1.50 and a high estimate of 5.00. The average target predicts an increase of 691.94% from the current stock price of 0.43.
Analyst Consensus: Buy
* Price targets were last updated on May 14, 2026.
Analyst Ratings
The average analyst rating for MDxHealth stock from 6 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 6 | 6 | 6 | 6 | 5 | 4 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 1 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 6 | 6 | 6 | 6 | 6 | 6 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Lake Street | Lake Street | Buy Maintains $9 → $5 | Buy | Maintains | $9 → $5 | +1,071.51% | May 14, 2026 |
| William Blair | William Blair | Hold Downgrades n/a | Hold | Downgrades | n/a | n/a | May 14, 2026 |
| Craig-Hallum | Craig-Hallum | Buy Maintains $3 | Buy | Maintains | $3 | +602.91% | May 14, 2026 |
| BTIG | BTIG | Buy Reiterates $7 → $4 | Buy | Reiterates | $7 → $4 | +837.21% | May 14, 2026 |
| TD Cowen | TD Cowen | Buy Maintains $7 → $1.5 | Buy | Maintains | $7 → $1.5 | +251.45% | May 14, 2026 |
Financial Forecast
Revenue This Year
112.45M
from 107.88M
Increased by 4.24%
Revenue Next Year
126.55M
from 112.45M
Increased by 12.54%
EPS This Year
-0.54
from -0.51
EPS Next Year
-0.45
from -0.54
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 113.7M | 133.9M | |
| Avg | 112.5M | 126.6M | |
| Low | 111.2M | 120.5M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 5.4% | 19.0% | |
| Avg | 4.2% | 12.5% | |
| Low | 3.1% | 7.2% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | -0.54 | -0.45 | |
| Avg | -0.54 | -0.45 | |
| Low | -0.54 | -0.45 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | - | |
| Avg | - | - | |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.